222 related articles for article (PubMed ID: 29968962)
1. Convergent evolution of 11p allelic loss in multifocal Wilms tumors arising in WT1 mutation carriers.
Valind A; Wessman S; Pal N; Karlsson J; Jonson T; Sandstedt B; Gisselsson D
Pediatr Blood Cancer; 2018 Nov; 65(11):e27301. PubMed ID: 29968962
[TBL] [Abstract][Full Text] [Related]
2. Deletion of WT1 and WIT1 genes and loss of heterozygosity on chromosome 11p in Wilms tumors in Japan.
Kaneko Y; Takeda O; Homma C; Maseki N; Miyoshi H; Tsunematsu Y; Williams BG; Saunders GF; Sakurai M
Jpn J Cancer Res; 1993 Jun; 84(6):616-24. PubMed ID: 8393432
[TBL] [Abstract][Full Text] [Related]
3. Novel WT1 mutation, 11p LOH, and t(7;12) (p22;q22) chromosomal translocation identified in a Wilms' tumor case.
Löbbert RW; Klemm G; Grüttner HP; Harms D; Winterpacht A; Zabel BU
Genes Chromosomes Cancer; 1998 Apr; 21(4):347-50. PubMed ID: 9559347
[TBL] [Abstract][Full Text] [Related]
4. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
Segers H; Kersseboom R; Alders M; Pieters R; Wagner A; van den Heuvel-Eibrink MM
Eur J Cancer; 2012 Nov; 48(17):3249-56. PubMed ID: 22796116
[TBL] [Abstract][Full Text] [Related]
5. Paternally inherited WT1 mutation plus uniparental disomy of 11p may be an essential mechanism for development of WT1-mutated familial Wilms tumor.
Sato Y; Haruta M; Kaneko Y; Nakasato Y; Kurosawa H; Yoshihara S
Pediatr Blood Cancer; 2019 Jan; 66(1):e27442. PubMed ID: 30221469
[No Abstract] [Full Text] [Related]
6. Stratification of Wilms tumor by genetic and epigenetic analysis.
Scott RH; Murray A; Baskcomb L; Turnbull C; Loveday C; Al-Saadi R; Williams R; Breatnach F; Gerrard M; Hale J; Kohler J; Lapunzina P; Levitt GA; Picton S; Pizer B; Ronghe MD; Traunecker H; Williams D; Kelsey A; Vujanic GM; Sebire NJ; Grundy P; Stiller CA; Pritchard-Jones K; Douglas J; Rahman N
Oncotarget; 2012 Mar; 3(3):327-35. PubMed ID: 22470196
[TBL] [Abstract][Full Text] [Related]
7. Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm.
Royer-Pokora B; Busch M; Beier M; Duhme C; de Torres C; Mora J; Brandt A; Royer HD
Hum Mol Genet; 2010 May; 19(9):1651-68. PubMed ID: 20106868
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
[TBL] [Abstract][Full Text] [Related]
9. Identification of a new WT1 mutation in a sporadic Wilms' tumour.
Santos AC; Boavida MG; Costa A; Osorio-Almeida L
Biochim Biophys Acta; 1998 Aug; 1407(2):109-13. PubMed ID: 9685601
[TBL] [Abstract][Full Text] [Related]
10. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation.
Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI
Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820
[TBL] [Abstract][Full Text] [Related]
11. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
12. Bilateral Wilms tumor in a boy with severe hypospadias and cryptochidism due to a heterozygous mutation in the WT1 gene.
Köhler B; Schumacher V; Schulte-Overberg U; Biewald W; Lennert T; l'Allemand D; Royer-Pokora B; Grüters A
Pediatr Res; 1999 Feb; 45(2):187-90. PubMed ID: 10022588
[TBL] [Abstract][Full Text] [Related]
13. Inherited WT1 mutation in Denys-Drash syndrome.
Coppes MJ; Liefers GJ; Higuchi M; Zinn AB; Balfe JW; Williams BR
Cancer Res; 1992 Nov; 52(21):6125-8. PubMed ID: 1327525
[TBL] [Abstract][Full Text] [Related]
14. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
15. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
Grundy P; Telzerow P; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
[TBL] [Abstract][Full Text] [Related]
17. Uniparental disomy occurs infrequently in Wilms tumor patients.
Grundy P; Wilson B; Telzerow P; Zhou W; Paterson MC
Am J Hum Genet; 1994 Feb; 54(2):282-9. PubMed ID: 8304345
[TBL] [Abstract][Full Text] [Related]
18. WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study.
Perlman EJ; Grundy PE; Anderson JR; Jennings LJ; Green DM; Dome JS; Shamberger RC; Ruteshouser EC; Huff V
J Clin Oncol; 2011 Feb; 29(6):698-703. PubMed ID: 21189373
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of chromosome 11p imbalances in aniridia and Wilms tumor patients.
Busch M; Leube B; Thiel A; Schanze I; Beier M; Royer-Pokora B
Am J Med Genet A; 2013 May; 161A(5):958-64. PubMed ID: 23494989
[TBL] [Abstract][Full Text] [Related]
20. WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.
Cardoso LC; De Souza KR; De O Reis AH; Andrade RC; Britto AC; De Lima MA; Dos Santos AC; De Faria PS; Ferman S; Seuánez HN; Vargas FR
Oncol Rep; 2013 Jan; 29(1):315-20. PubMed ID: 23117548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
